申请人:Nippon Shinyaku Co., Ltd.
公开号:EP1243268A1
公开(公告)日:2002-09-25
The present invention is composed of a pharmaceutical composition for the therapy of nephritis which comprises an amide derivative represented by the following formula [1] or pharmaceutically acceptable salt thereof, as an active ingredient:
wherein R1 and R2 may be the same or different and each is hydrogen, alkyl which may be substituted, acyl, aryl which may be substituted, or an aromatic heterocyclic group which may be substituted; R3, R4, R5 and R6 may be the same or different and each is hydrogen, halogen, hydroxy, amino which may be substituted, alkyl which may be substituted, alkoxy or nitro and the like; and R7 represents cyclic amino which may be substituted or azabicycloalkylamino which may be substituted.
The pharmaceutical composition of the invention is useful for the therapy of nephritis.
本发明由一种治疗肾炎的药物组合物组成,该药物组合物包括下式[1]代表的酰胺衍生物或其药学上可接受的盐作为活性成分:
其中 R1 和 R2 可以相同或不同,各自为氢、可被取代的烷基、酰基、可被取代的芳基或可被取代的芳香杂环基团;R3、R4、R5 和 R6 可以相同或不同,各自为氢、卤素、羟基、可被取代的氨基、可被取代的烷基、烷氧基或硝基等;R7 代表可被取代的环氨基或可被取代的氮杂环烷基氨基。
本发明的药物组合物可用于治疗肾炎。